Spatially explicit prioritization of human antibiotics and antineoplastics in Europe

Rik Oldenkamp*, Mark A. J. Huijbregts, Anne Hollander, Ann Versporten, Herman Goossens, Ad M. J. Ragas

*Corresponding author for this work

    Research output: Contribution to journalArticleAcademicpeer-review

    35 Citations (Web of Science)
    Original languageEnglish
    Pages (from-to)13-26
    Number of pages14
    JournalEnvironment International
    Volume51
    DOIs
    Publication statusPublished - Jan 2013

    Keywords

    • Pharmaceuticals
    • Prioritization
    • Risk assessment
    • Environment
    • Human health
    • Spatial variation
    • ENVIRONMENTAL RISK-ASSESSMENT
    • IONIZABLE ORGANIC-CHEMICALS
    • TANDEM MASS-SPECTROMETRY
    • SOLID-PHASE EXTRACTION
    • PERSONAL CARE PRODUCTS
    • HUMAN PHARMACEUTICALS
    • WASTE-WATER
    • AQUATIC ENVIRONMENT
    • VETERINARY MEDICINES
    • SURFACE WATERS

    Fingerprint

    Dive into the research topics of 'Spatially explicit prioritization of human antibiotics and antineoplastics in Europe'. Together they form a unique fingerprint.

    Cite this